Latest filing published 09 Apr 2024 for IPI Legacy Liquidation Co.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Timothy S. Nelson, listed as board member, appears in our data through filings on Impel Neuropharma Inc shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 19 November 2021 and the latest from 5 April 2024.
Every open-market trade on record is a purchase: 1 purchase worth €95k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 9 April 2024: a transaction, in Impel Neuropharma Inc. The most recent open-market purchase was published on 22 November 2021, 1,797 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations